JERECZEK, BARBARA ALICJA
 Distribuzione geografica
Continente #
EU - Europa 21.619
NA - Nord America 9.174
AS - Asia 5.330
SA - Sud America 185
AF - Africa 109
OC - Oceania 109
Continente sconosciuto - Info sul continente non disponibili 12
Totale 36.538
Nazione #
DE - Germania 10.320
US - Stati Uniti d'America 8.944
GB - Regno Unito 4.159
IT - Italia 2.676
CN - Cina 2.452
SE - Svezia 1.439
IE - Irlanda 700
IN - India 630
FR - Francia 559
SG - Singapore 496
TR - Turchia 455
KR - Corea 401
UA - Ucraina 338
FI - Finlandia 287
NL - Olanda 229
RU - Federazione Russa 216
HK - Hong Kong 212
ID - Indonesia 197
CA - Canada 196
EU - Europa 183
VN - Vietnam 173
DK - Danimarca 169
JP - Giappone 115
ES - Italia 104
AU - Australia 96
PL - Polonia 90
PH - Filippine 74
BE - Belgio 70
CH - Svizzera 61
CO - Colombia 59
MA - Marocco 59
BR - Brasile 55
GR - Grecia 37
PT - Portogallo 32
AT - Austria 30
CL - Cile 28
TW - Taiwan 26
AR - Argentina 21
IR - Iran 21
RO - Romania 20
MX - Messico 19
NO - Norvegia 18
TH - Thailandia 16
NG - Nigeria 13
NZ - Nuova Zelanda 13
CZ - Repubblica Ceca 12
IL - Israele 12
EG - Egitto 11
MY - Malesia 11
CR - Costa Rica 10
EC - Ecuador 10
PE - Perù 10
TN - Tunisia 10
HU - Ungheria 9
PK - Pakistan 8
ZA - Sudafrica 8
RS - Serbia 7
IS - Islanda 6
SC - Seychelles 6
SK - Slovacchia (Repubblica Slovacca) 6
BD - Bangladesh 5
BG - Bulgaria 4
HR - Croazia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EE - Estonia 3
JO - Giordania 3
LK - Sri Lanka 3
LU - Lussemburgo 3
SA - Arabia Saudita 3
SI - Slovenia 3
SY - Repubblica araba siriana 3
AD - Andorra 2
AM - Armenia 2
DO - Repubblica Dominicana 2
MN - Mongolia 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BT - Bhutan 1
BZ - Belize 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
IM - Isola di Man 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
PR - Porto Rico 1
TJ - Tagikistan 1
Totale 36.712
Città #
Frankfurt am Main 9.421
Southend 3.797
Chandler 1.323
Milan 971
Princeton 815
Seattle 726
Dublin 685
Wilmington 607
Ashburn 440
Beijing 416
Fairfield 411
Bengaluru 300
Nanjing 264
Des Moines 254
Redmond 242
Dearborn 238
Houston 230
Singapore 222
Woodbridge 215
Cambridge 211
Mountain View 198
Jacksonville 196
Ann Arbor 166
Phoenix 154
Toronto 153
Jinan 152
Sakarya 148
Redwood City 134
Hong Kong 125
Jakarta 122
Boardman 121
New York 116
Shanghai 113
Shenyang 108
Berlin 103
Rome 100
Hyderabad 97
Grafing 90
Helsinki 85
Dong Ket 77
Nanchang 77
Tianjin 66
Andover 65
Changsha 62
Eitensheim 59
Hebei 58
Medford 57
Bogotá 54
Brussels 54
Guangzhou 54
San Diego 54
Seoul 53
Hangzhou 52
Central District 46
Warsaw 46
Turin 44
Munich 43
Nuremberg 42
Serra 41
Haikou 39
London 38
Cinisello Balsamo 37
Jiaxing 37
Somerville 34
Tokyo 34
Athens 33
Florence 33
Roxbury 32
Pavia 31
Casablanca 30
Mumbai 29
Silver Spring 29
Boston 28
Bühl 28
Los Angeles 27
Verona 27
Istanbul 26
Kunming 26
Barcelona 25
Chicago 25
Zhengzhou 25
Fremont 24
Madrid 24
Melbourne 24
Ningbo 23
Rho 23
São Paulo 23
Upper Marlboro 23
Norwalk 22
Sydney 22
Washington 22
Taizhou 21
Chengdu 20
Duncan 19
Bologna 18
Falls Church 18
Menlo Park 18
Paris 17
San Francisco 17
Amsterdam 16
Totale 26.440
Nome #
Salvage stereotactic body radiotherapy for local prostate cancer recurrence after radiotherapy: a retrospective multicentre study of the GETUG 810
A novel nomogram to identify candidates for active surveillance among patients with ISUP Grade Group 1 or ISUP Grade Group 2 prostate cancer, according to multiparametric magnetic resonance imaging findings 291
Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer : a histology-validated study including 301 operated patients 247
Evaluation of target coverage and margins adequacy during CyberKnife Lung Optimized Treatment 243
Treatment of muscle-invasive bladder cancer in patients without comorbidities and fit for surgery: Trimodality therapy vs radical cystectomy. Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 228
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): Potential of imaging and biology (AIRC IG-22159) 222
Cisplatin, etoposide and continuous infusion bleomycin in patients with testicular germ cell tumors: efficacy and toxicity data from a retrospective study 212
Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT) 203
No increase in toxicity of pelvic irradiation when intensity modulation is employed: clinical and dosimetric data of 208 patients treated with post-prostatectomy radiotherapy 196
Association of quantitative mri-based radiomic features with prognostic factors and recurrence rate in oropharyngeal squamous cell carcinoma 194
[11C]Choline PET/CT impacts treatment decision making in patients with prostate cancer referred for radiotherapy 189
Linee guida carcinoma della prostata : AIRO, 2016 189
STRA-MI-VT (STereotactic RadioAblation by Multimodal Imaging for Ventricular Tachycardia) : rationale and design of an Italian experimental prospective study 177
Tossicità con radioterapia e brachiterapia 176
Repeated MRIs during Active Surveillance: natural history of prostatic lesions and upgrading rates 176
MR imaging for selection of patients for partial breast irradiation : a systematic review and meta-analysis 175
Salvage image-guided intensity modulated or stereotactic body reirradiation of local recurrence of prostate cancer 169
Machine Learning-Based Models for Prediction of Toxicity Outcomes in Radiotherapy 167
M. D. Anderson symptom inventory head neck (MDASI-HN) questionnaire: Italian language psychometric validation in head and neck cancer patients treated with radiotherapy ± systemic therapy – A study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 163
Voxel-based analysis unveils regional dose differences associated with radiation-induced morbidity in head and neck cancer patients 162
Adjuvant and salvage radiation therapy after prostatectomy : investigating beliefs and practices of radiation oncologists 161
Value of perfusion CT parameters, microvessl density and VEGF expression in differentiation of benign and malignant prostate tumours 157
Bladder preservation in non-metastatic muscle-invasive bladder cancer (MIBC): a single-institution experience 154
Perfusion CT is a valuable diagnostic method for prostate cancer: a prospective study of 94 patients 152
Head and neck cancer radiotherapy amid COVID‐19 pandemic : Report from Milan, Italy 151
Adjuvant radiotherapy treatment for soft tissue sarcoma of extremities and trunk. A retrospective mono-institutional analysis 151
Cytoreductive prostate radiotherapy in oligometastatic prostate cancer: A single centre analysis of toxicity and clinical outcome 147
Recent advances in radiation oncology 145
Robot-assisted radical prostatectomy : multiparametric MR imaging-directed intraoperative frozen-section analysis to reduce the rate of positive surgical margins 144
Chemioterapia versus naprzemienna chemio-radioterapia u chorych z ograniczona postacia drobnokomórkowego raka pluca 143
Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors 143
OLIGO-AIRO: a national survey on the role of radiation oncologist in the management of OLIGO-metastatic patients on the behalf of AIRO 142
Low Dose Rate Brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy : Practice and outcome analysis in a series of 2237 patients from 11 Institutions 141
Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series 139
Phase II prospective trial “Give Me Five” short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion : the impact of toxicity on quality of life (AIRC IG-13218) 138
"Give me five" ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approach 137
Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up (Prostate Cancer and Prostatic Diseases, (2020), 23, 1, (94-101), 10.1038/s41391-019-0160-3) 137
Mixup (Sample Pairing) Can Improve the Performance of Deep Segmentation Networks 137
Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionation 136
The QUBIC instrument for CMB polarization measurements 136
20 Gy in five fractions versus 8 Gy in one fraction in palliative radiotherapy of bone metastases : a multicenter randomized study 135
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 135
Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P) : inter-observer agreement between readers of different expertise levels 135
Beyond D'Amico risk classes for predicting recurrence after external beam radiotherapy for prostate cancer: the Candiolo classifier 134
COVID-19 outbreak and cancer radiotherapy disruption in Italy : Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 134
A qualitative investigation on patient empowerment in prostate cancer 131
CyberKnife®; Imaging-dose evaluation during IGRT-SRSand IGRT-SBRT treatments 130
Acute radiation dermatitis in breast cancer : topical therapy with vitamin E acetate in lipophilic gel 129
The PROCAINA (Prostate Cancer Indication Attitudes) Project (Part I): A survey among Italian radiation oncologists on post-operative radiotherapy in prostate cancer 129
Whole-body magnetic resonance imaging: Technique, guidelines and key applications 128
Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up 124
Predicting Pathological Features at Radical Prostatectomy in Patients with Prostate Cancer Eligible for Active Surveillance by Multiparametric Magnetic Resonance Imaging 123
Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis 122
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 122
Dose escalation for prostate cancer using the three-dimensional conformal dynamic arc technique : analysis of 542 consecutive patients 120
Correlation between EGFr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma 120
MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218) 120
Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches 120
A global Unified Dosimetry Index (gUDI) to evaluate simultaneous integrated boost radiotherapy plans in prostate cancer 119
COMBINED SURGERY AND POST-OPERATIVE RADIOTHERAPY OR CHEMORADIOTHERAPY FOR LOCALLY ADVANCED TONGUE CANCER 118
Three-times daily radiotherapy after chemotherapy in stage III non-small cell lung cancer. Single-institution prospective study 117
Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer : a review 116
Dosimetric Impact of Inter-Fraction Anatomical Changes in Carbon Ion Boost Treatment for High-Risk Prostate Cancer (AIRC IG 14300) 116
Volumetric modulated arc therapy with rapidarc (RA-IMRT) for gunaecological malignancies 115
Urinary bladder preservation for muscle-invasive bladder cancer: a survey among radiation oncologists of Lombardy, Italy 115
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300 115
Adaptive mathematical model of tumor response to radiotherapy based on CBCT data 113
Stereotactic body radiotherapy for castration-sensitive prostate cancer bone oligometastases 113
Mammella. Radioterapia del carcinoma della mammella 112
Domande dei lettori 111
Radiotherapy in prostate cancer patients with pelvic lymphocele after surgery: clinical and dosimetric data of 30 patients 111
Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence : A Multi-institutional Analysis 111
Adjuvant therapy in patients with ductal carcinoma in situ of the breast: The Pandora's box 111
PROACTA: a survey on the actual attitude of the Italian radiation oncologists in the management and prescription of hormonal therapy in prostate cancer patients 111
Late toxicity of image-guided hypofractionated radiotherapy for prostate : non-randomized comparison with conventional fractionation 110
Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom? 110
Intraoperative radiotherapy during radical prostatectomy for intermediate-risk to locally advanced prostate cancer: treatment technique and evaluation of perioperative and functional outcome vs standard radical prostatectomy, in a matched-pair analysis 109
Radioterapia trifrazionata (trt)e chemioterapia di induzione (ict) nei tumori polmonari non microcitomi ( nsclc) localmente avanzati: risultati preliminari 109
Influence of different urinary bladder filling levels and controlling regions of interest selection on deformable image registration algorithms 109
Comparing TomoHelical and TomoDirect in postmastectomy hypofractionated radiotherapy after immediate breast reconstruction 109
Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion : ad interim analysis and preliminary results of Phase II trial AIRC-IG-13218 108
Clinical risk analysis of the patient’s path in an Advanced Radiotherapy Center (A.R.C.) through F.M.E.A. method 108
Effects of sex and age on fat fraction, diffusion-weighted image signal intensity and apparent diffusion coefficient in the bone marrow of asymptomatic individuals: A cross-sectional whole-body mri study 108
Management of patients with cardiac implantable electronic devices (CIED) undergoing radiotherapy : a consensus document from Associazione Italiana Aritmologia e Cardiostimolazione (AIAC), Associazione Italiana Radioterapia Oncologica (AIRO), Associazione Italiana Fisica Medica (AIFM) 107
Intra- and inter-observer variability in breast tumour bed contouring and the controversial role of surgical clips 107
VERO (R) radiotherapy for low burden cancer: 789 patients with 957 lesions 107
Electronic portal imaging registration in breast cancer radiotherapy verification : Analysis of inter-observer agreement among different categories of health practitioners 106
Model-supported radiotherapy personalization : in silico test of hyper- and hypo-fractionation effects 106
Acute and intermediate toxicity of 3-week radiotherapy with simultaneous integrated boost using TomoDirect: prospective series of 287 early breast cancer patients 106
Locoregionally advanced nasopharyngeal carcinoma : induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin : a phase II study 105
Reporting combined outcomes with Trifecta and survival, continence, and potency (SCP) classification in 337 patients with prostate cancer treated with image-guided hypofractionated radiotherapy 105
Use of artificial neural networks to predict acute rectal toxicity after external beam radiotherapy for prostate carcinoma 104
Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients 104
What is the role of radiotherapy in the treatment of mucosal melanoma of the head and neck? 103
Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective Studies 103
Cancer treatment-induced oral mucositis 102
Clinical evaluation and disease management of PI-RADS 3 lesions. Analysis from a single tertiary high-volume center 102
Ultrasound-guided transcutaneous Tru-Cut biopsy to diagnose laryngopharyngeal masses : a pilot study 101
Analysis of tumor control probability (TCP) and normal tissue complication probability (NTCP) in 40 prostate cancer patients treated with 2 different techniques of 3D-conformal radiation therapy (3D-CRT) 101
Assessment of carotid artery dose in the treatment of nasopharyngeal cancer with IMRT versus conventional radiotherapy 100
Totale 14.344
Categoria #
all - tutte 99.808
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.808


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019110 0 0 0 0 0 0 0 0 0 0 0 110
2019/20203.580 550 89 106 388 186 314 456 195 531 454 215 96
2020/20213.660 286 217 178 194 293 401 208 193 562 189 602 337
2021/20224.110 167 139 135 163 258 301 266 269 379 447 377 1.209
2022/20236.046 741 571 511 639 511 1.088 223 401 647 119 400 195
2023/202413.481 194 309 336 258 965 526 2.258 2.001 989 1.928 2.277 1.440
Totale 39.065